TP53 and sarcoma: For what concerns the tumor spectrum modifications introduced by the alymphocytic Rag2−/−;Il2rg−/− genotype, as in p53−/− mice, also in p53+/− mice, this resulted in a reduction of lymphomas in favor of sarcomas.